Claudio Martin Pereira Pereira

Dr. Claudio Martin Pereira Pereira

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HSHélio A Stefani
Hélio A Stefani
COCarlindo B. Oliveira
Carlindo B. Oliveira
RARoberta B. Almeida
Roberta B. Almeida
CPClaudio Martin Pereira Pereira
Claudio Martin Pereira Pereira
RBRodolpho C. Braga
Rodolpho C. Braga
CNCristina Nogueira
Cristina Nogueira

1 March 2007 in Tetrahedron Letters
Verified
Journal Article
Closed access
KGKarla P. Guzen
Karla P. Guzen
AGAlexandre S. Guarezemini
Alexandre S. Guarezemini
AÓAline T.G. Órfão
Aline T.G. Órfão
RCRodrigo Cella
Rodrigo Cella
CPClaudio Martin Pereira Pereira
Claudio Martin Pereira Pereira
HSHélio A. Stefani
Hélio A. Stefani

1 October 2005 in Tetrahedron Letters
Verified
Journal Article
Closed access
HSHélio A. Stefani
Hélio A. Stefani
CPClaudio Martin Pereira Pereira
Claudio Martin Pereira Pereira
RARoberta B. Almeida
Roberta B. Almeida
RBRodolpho C. Braga
Rodolpho C. Braga
KGKarla P. Guzen
Karla P. Guzen
RCRodrigo Cella
Rodrigo Cella

19 November 2013 in Journal of the American Oil Chemists' Society
Verified
Journal Article
Closed access
PDF file
MSMarco A. Z. dos Santos
Marco A. Z. dos Santos
TATatiana V. R. Alicieo
Tatiana V. R. Alicieo
CPClaudio Martin Pereira Pereira
Claudio Martin Pereira Pereira
GRGuillermo Ramis‐Ramos
Guillermo Ramis‐Ramos
CMCarla Rosane Rosane Barboza Barboza Mendonça
Carla Rosane Rosane Barboza Barboza Mendonça

1 January 2010 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
LPLucas Pizzuti
Lucas Pizzuti
PMPaula L.G. Martins
Paula L.G. Martins
BRBruna A. Ribeiro
Bruna A. Ribeiro
FQFrank Quina
Frank Quina
Ernani PintoErnani Pinto
Ernani Pinto
CPClaudio Martin Pereira Pereira
Claudio Martin Pereira Pereira
An ultrasound-assisted preparation of a series of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole-1-carboximidamides that proceeds via the efficient reaction of chalcones with aminoguanidine hydrochloride under clean conditions is described.

8 March 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
RMRosiane M. Martins
Rosiane M. Martins
FNFernanda Nedel
Fernanda Nedel
VGVictoria B. S. Guimarães
Victoria B. S. Guimarães
ASAdriana Fernandes da Silva
Adriana Fernandes da Silva
PCPio Colepicolo
Pio Colepicolo
Rafael Guerra LundRafael Guerra Lund
Rafael Guerra Lund
Background: Macroalgae are sources of bioactive compounds due to the large number of secondary metabolites they synthesize. The Antarctica region is characterized by extreme weather conditions and abundant aggregations of macroalgae. However, current knowledge on their biodiversity and their potential for bio-prospecting is still fledging. This study evaluates the antimicrobial and cytotoxic activity of different extracts of four macroalgae (Cystosphaera jacquinotii, Iridaea cordata, Himantothallus grandifolius, and Pyropia endiviifolia) from the Antarctic region against cancer and non-cancer cell lines. Methods: The antimicrobial activity of macroalgae was evaluated by the broth microdilution method. Extracts were assessed against Staphylococcus aureus ATCC 19095, Enterococcus faecalis ATCC 4083, Escherichia coli ATCC29214, Pseudomonas aeruginosa ATCC 9027, Candida albicans ATCC 62342, and the clinical isolates from the human oral cavity, namely, C. albicans (3), C. parapsilosis, C. glabrata, C. lipolytica, and C. famata. Cytotoxicity against human epidermoid carcinoma (A-431) and mouse embryonic fibroblast (NIH/3T3) cell lines was evaluated with MTT colorimetric assay. Results: An ethyl acetate extract of H. grandifolius showed noticeable antifungal activity against all fungal strains tested, including fluconazole-resistant samples. Cytotoxicity investigation with a cancer cell line revealed that the ethyl acetate extract of I. cordata was highly cytotoxic against A-431 cancer cell line, increasing the inhibitory ratio to 91.1 and 95.6% after 24 and 48 h exposure, respectively, for a concentration of 500 μg mL−1. Most of the algal extracts tested showed little or no cytotoxicity against fibroblasts. Conclusion: Data suggest that macroalgae extracts from Antarctica may represent a source of therapeutic agents. HIGHLIGHTS • Different macroalgae samples from Antarctica were collected and the lyophilized biomass of each macroalgae was extracted sequentially with different solvents • The antimicrobial and anticancer potential of macroalgae extracts were evaluated • Ethyl acetate extract of H. grandifolius showed noticeable antifungal activity against all the fungal strains tested, including fluconazole-resistant samples • Ethyl acetate extract of I. cordata was highly cytotoxic against the A-431 cancer cell line • Most of the algal extracts tested showed little or no cytotoxicity against normal cell lines